High Dose Vs Low Dose IV Iron, Which One To Choose?
Overview
This lecture by Dr. Yasser Faden compares high-dose and low-dose intravenous iron therapies, discussing evidence-based recommendations and practical considerations in clinical decision-making. It provides insights on achieving optimal patient outcomes, highlighting the efficacy and convenience of modern IV iron formulations in correcting iron deficiency anemia efficiently and safely.
- Reduced number of infusions
- Lower risk of hypersensitivity reactions
- Slower iron replenishment
- Lower efficacy in improving hemoglobin levels
- It requires more frequent administration
- It leads to faster iron repletion
- It has a lower cost per infusion
- It is less effective than low-dose FCM
- Increased risk of iron overload in certain patients
- Reduced efficacy in replenishing iron stores
- Longer infusion times
- Higher incidence of gastrointestinal side effects
- A patient with mild iron deficiency anemia and stable hemoglobin
- A patient with chronic kidney disease (CKD) and significant iron deficiency
- A patient with iron deficiency anemia who prefers multiple small infusions
- A patient with iron overload disorder
- The patient requires rapid iron correction
- The patient requires rapid iron correction
- Low-dose FCM has better long-term outcomes
- High-dose FCM is less effective
The CME certification is provided for live webinar attendance only.
GCC-FCM-2500035 I Date of preparation: October 2025



